Nervous System Diseases

1,005 trials 421 recruiting

Filter these 1,005 trials by phase, country and sponsor.

Open in Search →

An open-label study to assess safety, efficacy, and cellular kinetics of YTB323 in treatment-resistant generalized myasthenia gravis Recruiting

2024-513589-20-00 Treatment-resistant generalized Myasthenia Gravis 9 2025-07-29
ADAPT: Treatment of Agitated behaviour in patients with Dementia non-responsive to guideline recommended interventions by Argued Personalise… Recruiting

2024-510601-29-00 Dementia 6 2025-07-23
Recombinant coagulation Factor VIIa administered at the earliest time for the treatment of stroke caused by bleeding in the brain - FASTEST… Recruiting

2024-517383-28-00 Acute haemorrhagic stroke 5 2025-07-21
A multicentre, randomised, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of BP1.4979 in adult p… Recruiting

2024-517987-46-00 Essential tremor 4 2025-07-21
DARIdorexant efficacy on the COGnitive performance in patients with chronic insomnia disorder. DARI-COG Study Recruiting

2024-517768-52-00 Insonnia cronica 6 2025-07-11
A study to learn how zilucoplan moves throughout the body over time and how safe it is in children with generalized myasthenia gravis Recruiting

2022-502072-23-00 Generalized Myasthenia Gravis 10 2025-07-11
Effectiveness of a Nerve Block in the Back of the Head for Treating Headaches Caused by Bleeding in the Brain Recruiting

2025-520619-15-00 headache pain related to SAH 4 2025-07-11
Bevacizumab for the treatment of cerebral RAdiation Induced NecrosiS (BRAINS) study: A multicenter, open-label, randomized clinical trial to… Recruiting

2024-512466-34-00 High grade glioma (HGG) 5 2025-07-10
A Study to Assess the Adverse Events and Change in Disease Activity of Atogepant Oral Tablets in Pediatric Participants with Chronic Migrain… Recruiting

2024-513836-28-00 Chronic Migraine 5 2025-06-23
Immediate versus delayed treatment with azathioprine or rituximab in anti-myelin oligodendrocytes glycoprotein (anti-MOG) antibodies associa… Recruiting

2024-516243-81-00 myelin oligodendrocytes glycoprotein antibody associate 5 2025-06-23
Nuovo impiego del farmaco Mirtazapina nella cura di pazienti affette da sindrome di Rett, con disturbi tipici della patologia. Recruiting

2024-515411-21-00 Rett Syndrome (RTT) 4 2025-06-18
Evaluating safety, efficacy and pharmacokinetics of a modified regimen of ublituximab (ENHANCE) Recruiting

2024-519284-18-00 Relapsing multiple sclerosis 5 2025-06-18
The use of therapeutic monitoring of ocrelizumab serum concentrations for personalized pharmacotherapy of relapsing-remitting and primary pr… Recruiting

2024-514549-12-00 Multiple Sclerosis 6 2025-06-16
A study to test the safety and tolerability of Lu AH69593 in adults that are healthy or have narcolepsy. Recruiting

2024-511073-29-00 Narcolepsy 3 2025-06-13
To investigate the safety and efficacy of a novel investigational compound against neurological diseases such as Parkinson's disease in heal… Recruiting

2025-521357-17-00 Parkinson's disease 1 2025-06-13
A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of remibrutinib in patient… Recruiting

2023-510026-32-00 Generalized Myasthenia Gravis 5 2025-06-11
Plasma cell targeting in ME/CFS Recruiting

2024-520094-13-00 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 4 2025-06-11
A Study of ORX750 in Subjects with Narcolepsy and Idiopathic Hypersomnia Recruiting

2024-518929-15-00 Narcolepsy and Idiopathic Hypersomnia 4 2025-06-09
The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind tr… Recruiting

2024-517981-40-00 Chronic Migraine 5 2025-06-06
PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients Recruiting

2023-510488-36-01 Chronic obstructive pulmonary disease (COPD), amyotroph 4 2025-06-01
A Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants with IH Recruiting

2024-517712-29-00 Idiopathic Hypersomnia (IH) 4 2025-05-27
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) Recruiting

2024-514937-39-00 Dravet Syndrome 5 2025-05-20
Efficacy of daily IV administration of dornase alfa for up to 14 days post subarachnoid haemorrhage on functional independence at 6 months: … Recruiting

2023-509627-40-01 subarachnoid hemorrhage 5 2025-05-15
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia Recruiting

2024-519822-18-00 Narcolepsy Type 1, Type 2 and Idiopathic Hypersomnia 10 2025-05-14